Zevra Therapeutics (ZVRA) Payables (2014 - 2026)
Zevra Therapeutics' Payables came in at $13.67 million for Q3 2026, up 23.5% from $11.07 million a year earlier but down 2.1% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Payables (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Payables was $11.6 million, down 54.4% from FY2024.
- Payables carries a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
- Going back by year, Payables was $25.46 million in FY2024 (-10.4%), $28.4 million in FY2023 (+360.4%), $6.17 million in FY2022 (+103.1%) and $3.04 million in FY2021 (-54.3%).
- The five-year range for quarterly Payables is $2.58 million (Q1 2022) to $28.4 million (Q4 2023).
- Year-over-year, Payables increased in 1 of the last eight quarters, with an average decline of 23.3%.
- The fastest year-over-year change in Payables over five years came in Q4 2023 (growth of 360.4%), and the weakest in Q3 2025 (a decline of 54.7%).
- Business Quant data shows ZVRA's Payables at $13.96 million (Q2 2026), $11.69 million (Q1 2026) and $11.6 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 13.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 13.67 Mn |
| Jun 30, 2026 | 13.96 Mn |
| Mar 31, 2026 | 11.69 Mn |
| Dec 31, 2025 | 11.60 Mn |
| Sep 30, 2025 | 11.07 Mn |
| Jun 30, 2025 | 15.84 Mn |
| Mar 31, 2025 | 17.82 Mn |
| Dec 31, 2024 | 25.46 Mn |
| Sep 30, 2024 | 24.46 Mn |
| Jun 30, 2024 | 20.45 Mn |
| Mar 31, 2024 | 22.79 Mn |
| Dec 31, 2023 | 28.40 Mn |
| Sep 30, 2023 | 13.08 Mn |
| Jun 30, 2023 | 10.51 Mn |
| Mar 31, 2023 | 10.10 Mn |
| Dec 31, 2022 | 6.17 Mn |
| Sep 30, 2022 | 4.28 Mn |
| Jun 30, 2022 | 3.60 Mn |
| Mar 31, 2022 | 2.58 Mn |
| Dec 31, 2021 | 3.04 Mn |
API Access
Zevra Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();